Latest Zuventus News & Updates

New Delhi, May 16 (IANS) Emcure Pharmaceuticals on Saturday said the United States Food and Drug Administration (US FDA) completed a current Good Manufacturing Practices (cGMP) inspection at its formulations manufacturing facility in Sanand, Ahmedabad, Gujarat, and issued a Form 483 with seven observations.The inspection was conducted between May 6 and May 15, 2026, at the company’s facility located in the G.I.D.C. industrial area in Taluka-Sanand, Ahmedabad. According to the company, the obse…